All News

For some patients with non-small cell lung cancer, removing part of the lobe rather than the entire lobe still provides benefit, study results show.

The Inflation Reduction Act is decreasing the out-of-pocket costs for multiple oncology drugs.

Researchers conducting the VISTA-101 study will assess the safety and efficacy of KVA12123 alone and with Keytruda, in addition to determining the recommended dose of the therapy.

Treatment for patients with non-small cell lung cancer has evolved to include immunotherapy after surgery and chemotherapy.

After receiving clean cancer scans, I rewarded myself with a trip to the thrift shop.

Some factors may increase the risk for anxiety and depression in older patients with metastatic cancer including distress related to physical symptoms, relationships, healthy lifestyle and communication with their health care team.

Patients with stage 3 colon cancer who reported physical activity after surgical resection may derive a survival benefit and may prolong disease recurrence.

I felt a kinship with the main character in the book, “A Man Called Ove,” though luckily, I had a purpose after my wife died of melanoma, and that helped to keep me going.

After the COVID-19 pandemic broadened usage of telehealth, patients with myeloma now have more access to experts in their disease.

After leaving the hospital, I craved the security and support my cancer care team provided me.

Childhood cancer survivors tend to die of the same factors as the general population, though at an earlier age. Research showed, though, that these risks can be modified.

I developed tuberculosis — a rare but dangerous effect of certain bladder cancer treatments.

A pharmaceutical company initiated a phase 1b study in patients with platinum-resistant, ARID1a-mutated ovarian carcinoma.

The use of ChatGPT (an artificial intelligence platform) tended to produce reliable cancer-related information in most circumstances, but patient-provider communication is still key, an expert said.

When survivorship becomes long-term, it can be an adjustment to move from active treatment to periodic surveillance.

I had what I thought was a canker sore that didn't heal. It ended up being cancer.

Two clinical trials investigating Keytruda plus Lenvima will be discontinued after the drug duo was not superior to other regimens for melanoma and colorectal cancer subsets.

When I was first diagnosed, I wasn’t sure what kind of support to ask for, but now I’m thankful to have many wonderful forms of support around me.

After hearing others' cancer stories, I found myself feeling "less than" because I didn't undergo radiation and chemotherapy.

Rybrevant outperformed other therapies for patients with exon 20 insertion-mutant, advanced non-small cell lung cancer in a clinical trial, highlighting the importance of personalized medicine.

Long-term data showed that the addition of Imbruvica did not improve overall survival in patients with marginal zone lymphoma or mantle cell lymphoma.

There are certain side effects from Elahere — a newly approved ovarian cancer drug — that patients taking the treatment should look out for, an expert said.

Nowadays, I think of myself more as a cancer survivor and advocate than patient. Here's what I learned along the way.

From the reveal of Christine McVie’s cause of death to cancer news from Hugh Jackman and a U.S. congressman, here’s what’s happening in the oncology space this week.

This analysis of the KEYNOTE-826 trial focused on health-related quality of life in patients with persistent, recurrent or metastatic cervical cancer.

The day I got diagnosed with cancer, I went from “person” to “patient” — and the title has followed me ever since.

Social media, including Facebook groups, can help connect patients with rare cancers like granulosa cell tumors to researchers, allowing them to learn more about disease management.

After being diagnosed with aggressive bone cancer, I had to accept that much of my life was going to change.

Immunotherapy treatment with Opdivo before surgery improved recurrence-free survival and overall survival at five years in patients with non-small cell lung cancer.

Interim findings from a clinical trial showed that adding Lynparza and Imfinzi to an Avastin and chemotherapy regimen tended to improve the time patients lived before their disease got worse.